VAXXINITY INC-A (VAXX) Stock Analyst Earnings Estimates
NASDAQ:VAXX - Nasdaq - US92244V1044 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 560K | 70K -87.50% | -100.00% | 31.671M | 40.698M 28.50% | 74.763M 83.70% | 145.97M 95.24% | 234.72M 60.80% | |||||
| EBITDA YoY % growth | -13.55M | -31.56M -132.92% | -123.98M -292.84% | -76.612M 40.07% | -95.217M 24.56% | -108.946M -94.37% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -13.66M | -32.28M -136.31% | -125.08M -287.48% | -77.459M 39.25% | -61.191M 23.29% | -52.962M 9.13% | -60.907M -15.00% | -59.451M 2.39% | -49.555M 16.65% | -27.418M 44.67% | 37.391M 236.37% | 120.22M 221.52% | |
| Operating Margin | N/A | -5,764.29% | -178,685.71% | N/A | N/A | N/A | N/A | -187.71% | -121.76% | -36.67% | 25.62% | 51.22% | |
| EPS YoY % growth | N/A | N/A | N/A | -0.61 62.05% | -0.47 21.80% | -0.39 17.39% | -0.40 -2.63% | -0.42 -5.13% | -0.42 | -0.39 7.32% | -0.33 15.79% | -0.27 18.75% |
All data in USD
| Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.10 32.00% | -0.10 7.27% | -0.10 -2.00% | -0.08 20.00% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -13.441M 28.55% | -13.307M 7.78% | -13.173M 2.06% | -13.042M -11.95% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -0.10 33.33% | -0.12 | 0.02 | 18.30% |
| Q2 2023 Q2Q % growth | -0.11 21.43% | -0.16 | 0.05 | 30.42% |
| Q1 2023 Q2Q % growth | -0.15 | -0.16 | 0.01 | 8.09% |
| Q4 2022 Q2Q % growth | -0.16 15.79% | -0.16 | 0.00 | 1.96% |
| Q3 2022 Q2Q % growth | -0.15 37.50% | -0.16 | 0.01 | 5.12% |
| Q2 2022 Q2Q % growth | -0.14 | -0.36 | 0.22 | 60.78% |
| Q1 2022 Q2Q % growth | -0.15 | -0.37 | 0.22 | 59.15% |
| Q4 2021 Q2Q % growth | -0.19 | -0.37 | 0.18 | 48.26% |
| Q3 2021 Q2Q % growth | -0.24 | -0.13 | -0.11 | -81.00% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | 50K -58.33% | 50K | % | |
| Q2 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |